Utilising a proprietary quantitative strategy, Cogent manages public equity Funds including Islamic Global Equity, Global Equity, China Equity, Islamic SE Asia Equity and ASEAN Equity. In addition, Cogent manages a range of European regulated specialist investment vehicles and structured products which provide investors access to income producing assets.

For further information, email info@cogent-assets.com

Cogent has an excellent track-record of generating superior investment returns for clients, with an emphasis on risk management and transparency. Funds managed by the team have received top ratings from Citywire, S&P and Morningstar. 

Cogent Asset Management 

Cogent Asset Management Ltd, a specialist Fund Management boutique, was launched by Citywire AAA rated manager Ian Lancaster and Paul Bethell in September 2013.


Paul Bethell, CFA

Paul has 20 years experience as an equity analyst, strategist and fund manager, having worked for Reliance, Gulf Finance House and Insinger de Beaufort. 

The â€‹WSF Global Equity Fund, which has employed our core disciplined investment strategy since inception in 2010, currently holds a 5 star, 5 year rating from Morningstar.

Ian Lancaster, ASIP IFQ MBA 

Ian has 30 years experience of Fund Management, successfully investing long-only and absolute return equity funds for global institutions such as Reliance, AXA, General Accident and Aviva. 

Fund Management, Award Winning Islamic Fund Management

​This Website has been prepared for information only, and it does not represent either an offer to purchase or subscribe to shares of any Cell, or an advertisement for countries where the Cells are not registered for sale. Cogent Asset Management Ltd holds Fund Management License number FML/18/0040A granted under the Labuan Financial Services and Securities Act 2010. Registered address is Unit Level 4(A), Main Office Tower, Financial Park Complex, Jalan Merdeka, Labuan F.T 87000 Malaysia. Trident Fund Services (Guernsey) Limitedand World Shariah Funds PCC Ltd (“WSF“) are licensed and regulated by the Guernsey Financial Services Commission under the Protection of Investors (Bailiwick of Guernsey) Law, 1987 as amended. Company Registration Number: 51802. Cogent Asset Management Ltd believes that the information is correct at the date of production while obtained from carefully selected sources considered to be reliable. No warranty or representation is given to this effect and no liability can be assumed for the correctness or accuracy of the given information which may be subject to change at any time, without notice. Past performance provides neither a guarantee, nor an indication of future performance. Value of the shares and return they generate can fall as well as rise. Currency fluctuations, either up or down, may also affect value of the investment. Due to continuing market volatility and exchange rate fluctuations, the performance may be subject to significant changes over a short-term period. Investors should be aware that shares in the financial instruments entail investment risks, including the possible loss of the invested capital. Performance is usually calculated on the basis of the relevant NAV unless stated otherwise. Performance shown does not take account of any fees and costs associated with subscribing or redeeming shares. It is assumed that all dividends were reinvested. The full documentation required to make an investment, including the Scheme Particulars is available and may be obtained through Trident Fund Services (Guernsey) Limitedor www.wsffunds.com. Before investing in any WSF Cells investors should contact their financial adviser/legal adviser/tax adviser and refer to all relevant documents relating to the WSF and its particular Cell(s), such as the latest annual report and Offering Memorandum and relevant Supplement that specify the particular risks associated with the Cell, together with any specific restrictions applying, and the basis of dealing. In the event investors choose not to seek advice from a financial adviser/legal adviser/tax adviser, they should consider whether the WSF Cell is a suitable investment for them.